Skip to search formSkip to main contentSkip to account menu

difloxacin

Known as: 1-FFMPOC, 6-fluoro-1-(4-fluorophenyl)-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-quinolone-3-carboxylic acid, 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Ziel der In-vitro-Untersuchungen war die quantitative Erfassung des Grades der Sensitivitat von 42 Chlamydophila-psittaci… 
2004
2004
Thirty healthy Avine broiler chickens were allotted to 3 groups at 10 chickens per group. Pharmacokinetics of difloxacin was… 
2003
2003
Pharmacokinetics of difloxacin was investigated in 7 healthy cross-bred pigs following single intravenous, intramuscular and oral… 
2001
2001
This letter is in response to the article by Riddle et al. ([4][1]) that appeared in this journal in April 2000. As Chairholder… 
2000
2000
The minimal inhibitory concentrations(MICs) of enrofloxacin, danofloxacin and difloxacin for Pasteurella multocida were… 
1989
1989
Campylobacter pylori has been associated with the etiology of gastritis and duodenal ulcer. It has been shown that several drugs… 
1987
1987
The in vitro activity of difloxacin (A-56619) and A-56620, two new aryl-difluoroquinolones, was compared to that of other new… 
Highly Cited
1986
Highly Cited
1986
By using high-performance liquid chromatography, the metabolism and pharmacokinetics of difloxacin were characterized in humans… 
Highly Cited
1986
Highly Cited
1986
The in vitro antibacterial potencies of A-56619 and A-56620, two new aryl-fluoroquinolones, were compared with the potency of… 
1986
1986
The susceptibilities of 44 clinical strains and a reference strain (ATCC 23834) of Eikenella corrodens were determined by agar…